Header Logo

Connection

Charles Feldman to Streptococcus pneumoniae

Back to Details
This is a "connection" page, showing publications Charles Feldman has written about Streptococcus pneumoniae.
Charles Feldman
Connection Strength
6,956
Streptococcus pneumoniae
  1. Platelets and Their Role in the Pathogenesis of Cardiovascular Events in Patients With Community-Acquired Pneumonia. Front Immunol. 2020; 11:577303.
    View in: PubMed
    Score: 0,581
  2. Pneumococcal virulence factors in community-acquired pneumonia. Curr Opin Pulm Med. 2020 05; 26(3):222-231.
    View in: PubMed
    Score: 0,566
  3. Biofilm formation and induction of stress response genes is a common response of several serotypes of the pneumococcus to cigarette smoke condensate. J Infect. 2020 02; 80(2):204-209.
    View in: PubMed
    Score: 0,546
  4. Review manuscript: Mechanisms of platelet activation by the pneumococcus and the role of platelets in community-acquired pneumonia. J Infect. 2017 12; 75(6):473-485.
    View in: PubMed
    Score: 0,472
  5. The Role of Streptococcus pneumoniae in Community-Acquired Pneumonia. Semin Respir Crit Care Med. 2016 12; 37(6):806-818.
    View in: PubMed
    Score: 0,448
  6. Exposure of a 23F serotype strain of Streptococcus pneumoniae to cigarette smoke condensate is associated with selective upregulation of genes encoding the two-component regulatory system 11 (TCS11). Biomed Res Int. 2014; 2014:976347.
    View in: PubMed
    Score: 0,376
  7. Antimicrobial susceptibility of pneumococcal isolates causing bacteraemic pneumococcal pneumonia: analysis using current breakpoints and fluoroquinolone pharmacodynamics. Int J Antimicrob Agents. 2010 Jul; 36(1):95-7.
    View in: PubMed
    Score: 0,282
  8. Comparison of the effects of macrolides, amoxicillin, ceftriaxone, doxycycline, tobramycin and fluoroquinolones, on the production of pneumolysin by Streptococcus pneumoniae in vitro. J Antimicrob Chemother. 2007 Nov; 60(5):1155-8.
    View in: PubMed
    Score: 0,236
  9. Clarithromycin alone and in combination with ceftriaxone inhibits the production of pneumolysin by both macrolide-susceptible and macrolide-resistant strains of Streptococcus pneumoniae. J Antimicrob Chemother. 2007 Feb; 59(2):224-9.
    View in: PubMed
    Score: 0,225
  10. Pneumolysin as a vaccine and drug target in the prevention and treatment of invasive pneumococcal disease. Arch Immunol Ther Exp (Warsz). 2005 May-Jun; 53(3):189-98.
    View in: PubMed
    Score: 0,200
  11. Gender as a risk factor for both antibiotic resistance and infection with pediatric serogroups/serotypes, in HIV-infected and -uninfected adults with pneumococcal bacteremia. J Infect Dis. 2004 Jun 01; 189(11):1996-2000.
    View in: PubMed
    Score: 0,187
  12. The Global Burden of Community-Acquired Pneumonia in Adults, Encompassing Invasive Pneumococcal Disease and the Prevalence of Its Associated Cardiovascular Events, with a Focus on Pneumolysin and Macrolide Antibiotics in Pathogenesis and Therapy. Int J Mol Sci. 2023 Jul 03; 24(13).
    View in: PubMed
    Score: 0,176
  13. The role of pneumolysin in the pathogenesis of Streptococcus pneumoniae infection. Curr Opin Infect Dis. 2002 Jun; 15(3):235-9.
    View in: PubMed
    Score: 0,164
  14. Serotype-specific Cardiac Involvement in Pneumococcal Pneumonia. Clin Infect Dis. 2022 02 11; 74(3):507-508.
    View in: PubMed
    Score: 0,160
  15. Editorial: The Role of Platelet Activation in the Pathophysiology of HIV, Tuberculosis and Pneumococcal Disease. Front Immunol. 2021; 12:737016.
    View in: PubMed
    Score: 0,154
  16. Streptococcus pneumoniae respiratory tract infections. Curr Opin Infect Dis. 2001 Apr; 14(2):173-9.
    View in: PubMed
    Score: 0,151
  17. The Role of Streptococcus pneumoniae in Community-Acquired Pneumonia. Semin Respir Crit Care Med. 2020 Aug; 41(4):455-469.
    View in: PubMed
    Score: 0,143
  18. Recent advances in the epidemiology and prevention of Streptococcus pneumoniae infections. F1000Res. 2020; 9.
    View in: PubMed
    Score: 0,142
  19. Penicillin- and cephalosporin-resistant Streptococcus pneumoniae. Emerging treatment for an emerging problem. Drugs. 1999 Jul; 58(1):1-4.
    View in: PubMed
    Score: 0,134
  20. Pneumolysin as a potential therapeutic target in severe pneumococcal disease. J Infect. 2017 06; 74(6):527-544.
    View in: PubMed
    Score: 0,114
  21. HIV-related pneumococcal disease prevention in adults. Expert Rev Respir Med. 2017 03; 11(3):181-199.
    View in: PubMed
    Score: 0,113
  22. Streptococcus pneumoniae Serotypes and Mortality in Adults and Adolescents in South Africa: Analysis of National Surveillance Data, 2003 - 2008. PLoS One. 2015; 10(10):e0140185.
    View in: PubMed
    Score: 0,103
  23. Review: current and new generation pneumococcal vaccines. J Infect. 2014 Oct; 69(4):309-25.
    View in: PubMed
    Score: 0,094
  24. Factors associated with ceftriaxone nonsusceptibility of Streptococcus pneumoniae: analysis of South African national surveillance data, 2003 to 2010. Antimicrob Agents Chemother. 2014 Jun; 58(6):3293-305.
    View in: PubMed
    Score: 0,093
  25. Effects of cigarette smoke condensate on pneumococcal biofilm formation and pneumolysin. Eur Respir J. 2013 Feb; 41(2):392-5.
    View in: PubMed
    Score: 0,082
  26. The interaction of Streptococcus pneumoniae with intact human respiratory mucosa in vitro. Eur Respir J. 1992 May; 5(5):576-83.
    View in: PubMed
    Score: 0,081
  27. Comparison of bacteraemic community-acquired lobar pneumonia due to Streptococcus pneumoniae and Klebsiella pneumoniae in an intensive care unit. Respiration. 1991; 58(5-6):265-70.
    View in: PubMed
    Score: 0,074
  28. The effect of Streptococcus pneumoniae pneumolysin on human respiratory epithelium in vitro. Microb Pathog. 1990 Oct; 9(4):275-84.
    View in: PubMed
    Score: 0,073
  29. Association of serotypes of Streptococcus pneumoniae with disease severity and outcome in adults: an international study. Clin Infect Dis. 2007 Jul 01; 45(1):46-51.
    View in: PubMed
    Score: 0,058
  30. HIV and pneumococcal disease. Curr Opin Infect Dis. 2007 Feb; 20(1):11-5.
    View in: PubMed
    Score: 0,057
  31. Controversies in the treatment of pneumococcal community-acquired pneumonia. Future Microbiol. 2006 Oct; 1(3):271-81.
    View in: PubMed
    Score: 0,055
  32. Endocarditis and pericarditis complicating pneumococcal bacteraemia, with special reference to the adhesive abilities of pneumococci: results from a prospective study. Clin Microbiol Infect. 2006 Apr; 12(4):338-44.
    View in: PubMed
    Score: 0,053
  33. Community-acquired pneumonia due to penicillin-resistant pneumococci. N Engl J Med. 1985 Sep 05; 313(10):615-7.
    View in: PubMed
    Score: 0,051
  34. Altered PBP 2A and its role in the development of penicillin, cefotaxime, and ceftriaxone resistance in a clinical isolate of Streptococcus pneumoniae. Antimicrob Agents Chemother. 2005 May; 49(5):2002-7.
    View in: PubMed
    Score: 0,050
  35. CD4 T-lymphocyte subset counts in HIV-seropositive patients during the course of community-acquired pneumonia caused by Streptococcus pneumoniae. Clin Microbiol Infect. 2004 Jun; 10(6):587-9.
    View in: PubMed
    Score: 0,047
  36. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia. J Lab Clin Med. 2004 May; 143(5):269-83.
    View in: PubMed
    Score: 0,047
  37. Dual infection with Streptococcus pneumoniae and Mycobacterium tuberculosis in HIV-seropositive patients with community acquired pneumonia. Int J Tuberc Lung Dis. 2003 Dec; 7(12):1207-8.
    View in: PubMed
    Score: 0,045
  38. An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin Infect Dis. 2003 Jul 15; 37(2):230-7.
    View in: PubMed
    Score: 0,044
  39. Invasive pneumococcal disease burden in hospitalized adults in Bogota, Colombia. BMC Infect Dis. 2021 Oct 12; 21(1):1059.
    View in: PubMed
    Score: 0,039
  40. Bacteremic pneumococcal pneumonia in HIV-seropositive and HIV-seronegative adults. Chest. 1999 Jul; 116(1):107-14.
    View in: PubMed
    Score: 0,033
  41. Pneumolysin mediates heterotypic aggregation of neutrophils and platelets in vitro. J Infect. 2017 06; 74(6):599-608.
    View in: PubMed
    Score: 0,028
  42. Pneumolysin activates neutrophil extracellular trap formation. Clin Exp Immunol. 2016 06; 184(3):358-67.
    View in: PubMed
    Score: 0,027
  43. HIV Infection and the Epidemiology of Invasive Pneumococcal Disease (IPD) in South African Adults and Older Children Prior to the Introduction of a Pneumococcal Conjugate Vaccine (PCV). PLoS One. 2016; 11(2):e0149104.
    View in: PubMed
    Score: 0,026
  44. Antibiotic-resistant pneumococcal pneumonia. S Afr Med J. 1996 Jan; 86(1):28-30.
    View in: PubMed
    Score: 0,026
  45. The aetiology of severe community-acquired pneumonia and its impact on initial, empiric, antimicrobial chemotherapy. Respir Med. 1995 Mar; 89(3):187-92.
    View in: PubMed
    Score: 0,025
  46. Septic shock in the Intensive Care Unit, Hillbrow Hospital, Johannesburg. S Afr Med J. 1991 Aug 17; 80(4):181-4.
    View in: PubMed
    Score: 0,019
  47. Effect of Streptococcus pneumoniae on human respiratory epithelium in vitro. Infect Immun. 1989 Jul; 57(7):2006-13.
    View in: PubMed
    Score: 0,017
  48. Guideline for the management of upper respiratory tract infections. S Afr Med J. 2004 Jun; 94(6 Pt 2):475-83.
    View in: PubMed
    Score: 0,012
  49. Pneumolysin activates the synthesis and release of interleukin-8 by human neutrophils in vitro. J Infect Dis. 2002 Aug 15; 186(4):562-5.
    View in: PubMed
    Score: 0,010
  50. Surveillance of resistance in bacteria causing community-acquired respiratory tract infections. Clin Microbiol Infect. 2002; 8 Suppl 2:12-42.
    View in: PubMed
    Score: 0,010
  51. A study of acute community-acquired pneumonia, including details of cardiac changes. Q J Med. 1993 Oct; 86(10):669-75.
    View in: PubMed
    Score: 0,006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.